IHP Therapeutics

Manufacturing · California, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

930 Brittan Ave, San Carlos, California,...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About IHP Therapeutics

IHP Therapeutics is focused on drug development for urgent medical needs, specifically targeting acute vaso-occlusive crisis in sickle cell disease with their product IHP-102. This innovative treatment aims to empower individuals by being the first self-administered rescue therapeutic, allowing care to be provided in home settings. IHP-102 functions as a dual P-selectin and complement inhibitor, addressing key mechanisms of vaso-occlusion to alleviate pain and reduce tissue damage. The company primarily serves patients suffering from sickle cell disease, aiming to improve their quality of life.Explore more
IHP Therapeutics's Social MediaPopular SearchesIhp TherapeuticsIhp Therapeutics IncSIC Code 28,283NAICS Code 32,325Show more

IHP Therapeutics Org Chart

Rinko Ghosh, President & Chief Executive Officer at IHP Therapeutics
United States flag for contact location.

President & Chief Executive Officer

PhoneEmail

Is IHP Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to IHP Therapeutics

Compare insights from companies similar to IHP Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

IHP Therapeutics

<$5M
1-10
Private
-
2020
Rinko Ghosh, President & Chief Executive Officer at IHP Therapeutics
Rinko GhoshPresident & CEO
$5.2M
11-50
Private
-
2008
MK
Marina KangHR & Office Administrator
<$5M
11-50
Private
-
2009
<$5M
11-50
Private
<$5M
2007
ER
Eugene RickardSenior Analytical Chemist
<$5M
1-10
Private
-
-
<$5M
11-50
Private
-
2012
AI
Anita IlchevaChief Financial Officer
<$5M
1-10
Private
-
2004
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

IHP Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

IHP Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about IHP Therapeutics.

IHP Therapeutics Tech Stack

A closer look at the technologies used by IHP Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding IHP Therapeutics

What is IHP Therapeutics's official website?
IHP Therapeutics's official website is www.ihptherapeutics.com
What is IHP Therapeutics's Revenue?
IHP Therapeutics's revenue is <$5 Million
What is IHP Therapeutics's SIC code?
IHP Therapeutics's SIC: 28,283
What is IHP Therapeutics's NAICS code?
IHP Therapeutics's NAICS: 32,325
How many employees does IHP Therapeutics have?
IHP Therapeutics has 1-10 employees
What industry does IHP Therapeutics belong to?
IHP Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is IHP Therapeutics competition?
IHP Therapeutics top competitors include: Apexian Pharmaceuticals, InClinica, IND Directions, Sofpromed
What technology does IHP Therapeutics use?
Some of the popular technologies that IHP Therapeutics uses are: Google Cloud DNS, Sentry, Google Cloud Web Serving, Google Cloud Platform
What does IHP Therapeutics do?

IHP Therapeutics is focused on drug development for urgent medical needs, specifically targeting acute vaso-occlusive crisis in sickle cell disease with their product IHP-102. This innovative treatment aims to empower individuals by being the first self-administered rescue therapeutic, allowing care to be provided in home settings. IHP-102 function... s as a dual P-selectin and complement inhibitor, addressing key mechanisms of vaso-occlusion to alleviate pain and reduce tissue damage. The company primarily serves patients suffering from sickle cell disease, aiming to improve their quality of life.Read More

What are IHP Therapeutics social media links?
IHP Therapeutics Linkedin page
Is IHP Therapeutics a public company?
IHP Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about IHP Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.